Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results From the CANVAS Program
Circulation - United States
doi 10.1161/circulationaha.119.040057
Full Text
Open PDFAbstract
Available in full text
Date
May 28, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)